Toxic epidermal necrolysis: Five years of treatment experience from a burn unit

Journal of the American Academy of Dermatology

Volumn 67, Issue 4, 2012, Pages 630-635

  Firoz, Bahar F ^a   Henning, Jeffrey Scott ^b   Zarzabal, Lee Ann ^a   Pollock, Brad H ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b BROOKE ARMY MEDICAL CENTER   (United States)

Author keywords

area under the curve; AUC; body surface area; BSA; intravenous immunoglobulin; IVIg; nonsteroidal anti inflammatory drugs; NSAIDs; odds ratio; OR; receiver operating curve; ROC; TEN; toxic epidermal necrolysis

Indexed keywords

ALLOPURINOL; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; AZITHROMYCIN; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOSPORIN; IMMUNOGLOBULIN; LEVOFLOXACIN; NONSTEROID ANTIINFLAMMATORY AGENT; VANCOMYCIN; VORICONAZOLE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY SURFACE; BURN; CAUSE OF DEATH; COMORBIDITY; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METABOLIC SYNDROME X; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SCORTEN; SURVIVAL; TOXIC EPIDERMAL NECROLYSIS; TREATMENT DURATION;

ADULT; AGED; ALLOPURINOL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICONVULSANTS; ANTIMETABOLITES; AREA UNDER CURVE; BURN UNITS; BURNS; COMORBIDITY; DRUG COMBINATIONS; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; ROC CURVE; SULFADOXINE; TRIMETHOPRIM; YOUNG ADULT;

EID: 84866416260     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2011.12.014     Document Type: Article

References (15)

1. A. Lyell Toxic Epidermal Necrolysis: an eruption resembling scalding of the skin Br J Dermatol 68 1956 355 361
2. J.-C. Roujeau, J.P. Kelly, L. Naldi, B. Rzany, R.S. Stern, and T. Anderson Medication Use and the Risk of Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis N Engl J Med 333 1995 1600 1608
3. J.-C. Roujeau, J.-C. Guillaume, J.P. Fabre, D. Penso, M. Flechet, and P. Girre Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981-1985 Arch Dermatol 126 1990 37 42
4. F.A. Pereira, A.V. Mudgil, and D.M. Rosmarin Toxic epidermal necrolysis J Am Acad Dermatol 56 2007 181 200
5. S. Bastuji-Garin, N. Fouchard, M. Bertocchi, J.C. Roujeau, J. Revuz, and P. Wolkenstein SCORTEN: a severity-of-illness score for toxic epidermal necrolysis J Invest Dermatol 115 2000 149 153
6. J.T. Trent, R.S. Kirsner, P. Romanelli, and F.A. Kerdel Use of SCORTEN to accurately predict mortality in patients with toxic epidermal necrolysis in the United States Arch Dermatol 140 2004 890 892
7. C. Paul, P. Wolkenstein, H. Adle, J. Wechsler, H.J. Garchon, and J. Revuz Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis Br J Dermatol 134 1996 710 714
8. P. Wehrli, I. Viard, R. Bullani, J. Tschopp, and L.E. French Death receptors in cutaneous biology and disease J Invest Dermatol 115 2000 141 148
9. J. Hewitt, and A.D. Ormerod Toxic epidermal necrolysis treated with cyclosporin Clin Exp Dermatol 17 1992 264 265
10. J.M. Arevalo, J.A. Lorente, C. Gonzalez-Herrada, and J. Jimenez-Reyes Treatment of toxic epidermal necrolysis with cyclosporin A J Trauma 48 2000 473 478
11. D. Reese, J.S. Henning, K. Rockers, D. Ladd, and R. Gilson Cyclosporine for SJS/TEN: a case series and review of the literature Cutis 87 2011 24 29
12. C. Prins, F.A. Kerdel, R.S. Padilla, T. Hunziker, S. Chimenti, and I. Viard Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases Arch Dermatol 139 2003 26 32
13. J.T. Trent, R.S. Kirsner, P. Romanelli, and F.A. Kerdel Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: The University of Miami Experience Arch Dermatol 139 2003 39 43
14. N. Bachot, J. Revuz, and J.C. Roujeau Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression Arch Dermatol 139 2003 33 36
15. Micromedex 2.0 Accessed July 22, 2011.